273 related articles for article (PubMed ID: 7849740)
1. Molecular genetics of oculocutaneous albinism.
Spritz RA
Hum Mol Genet; 1994; 3 Spec No():1469-75. PubMed ID: 7849740
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of oculocutaneous albinism.
Spritz RA
Semin Dermatol; 1993 Sep; 12(3):167-72. PubMed ID: 8217557
[TBL] [Abstract][Full Text] [Related]
3. [Genetics of oculocutaneous albinism].
Zühlke C; Stell A; Käsmann-Kellner B
Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
[TBL] [Abstract][Full Text] [Related]
4. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
[TBL] [Abstract][Full Text] [Related]
5. [Human oculocutaneous albinism. From clinical observation to molecular biology].
Aquaron R
Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
[TBL] [Abstract][Full Text] [Related]
8. [Oculocutaneous and ocular albinism].
Kubasch AS; Meurer M
Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
[TBL] [Abstract][Full Text] [Related]
9. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
[TBL] [Abstract][Full Text] [Related]
10. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
Giebel LB; Tripathi RK; King RA; Spritz RA
J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
[TBL] [Abstract][Full Text] [Related]
11. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
[TBL] [Abstract][Full Text] [Related]
13. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.
Teramae A; Kobayashi Y; Kunimoto H; Nakajima K; Suzuki T; Tsuruta D; Fukai K
J Invest Dermatol; 2019 May; 139(5):1143-1149. PubMed ID: 30447237
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
Oetting WS; King RA
Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
[TBL] [Abstract][Full Text] [Related]
16. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.
Passmore LA; Kaesmann-Kellner B; Weber BH
Hum Genet; 1999 Sep; 105(3):200-10. PubMed ID: 10987646
[TBL] [Abstract][Full Text] [Related]
17. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
[TBL] [Abstract][Full Text] [Related]
18. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
19. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
20. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
Onojafe IF; Adams DR; Simeonov DR; Zhang J; Chan CC; Bernardini IM; Sergeev YV; Dolinska MB; Alur RP; Brilliant MH; Gahl WA; Brooks BP
J Clin Invest; 2011 Oct; 121(10):3914-23. PubMed ID: 21968110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
